An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate

Prostate

Volumn 71, Issue 11, 2011, Pages 1139-1150

  Haverkamp, Jessica M ^a,b   Charbonneau, Bridget ^b   Crist, Scott A ^a   Meyerholz, David K ^c   Cohen, Michael B ^c   Snyder, Paul W ^a   Svensson, Robert U ^c   Henry, Michael D ^c   Wang, Hsing Hui ^a   Ratliff, Timothy L ^a,d,e  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Purdue University   (United States)

^e University of Iowa Carver College of Medicine ^*  (United States)

Author keywords

C57 Luc Pten mouse; CD8 T cell; mouse model; POET 3; prostate cancer; prostate inflammation; prostatitis

Indexed keywords

CHEMOKINE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FLOW CYTOMETRY; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

ACUTE DISEASE; ANIMALS; CELL PROLIFERATION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EPITOPES; INFLAMMATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATE; PROSTATITIS;

EID: 79958234229     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21327     Document Type: Article

References (47)

1. Alexander RB, Brady F, Ponniah S,. Autoimmune prostatitis: Evidence of T cell reactivity with normal prostatic proteins. Urology 1997; 50 (6): 893-899. (Pubitemid 28021107)
2. Collins MM, Stafford RS, O'Leary MP, Barry MJ,. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159 (4): 1224-1228. (Pubitemid 28172801)
3. Clemens JQ, Meenan RT, O'Keeffe-Rosetti MC, Gao SY, Brown SO, Calhoun EA,. Prevalence of prostatitis-like symptoms in a managed care population. J Urol 2006; 176 (2): 593-596; discussion 596. (Pubitemid 43927876)
4. Nickel JC, Downey J, Hunter D, Clark J,. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001; 165 (3): 842-845. (Pubitemid 32156292)
5. Moon TD, Hagen L, Heisey DM,. Urinary symptomatology in younger men. Urology 1997; 50 (5): 700-703. (Pubitemid 27494989)
6. Tan JK, Png DJ, Liew LC, Li MK, Wong ML,. Prevalence of prostatitis-like symptoms in Singapore: A population-based study. Singapore Med J 2002; 43 (4): 189-193.
7. Kunishima Y, Matsukawa M, Takahashi S, Itoh N, Hirose T, Furuya S, Takatsuka K, Mori M, Tsukamoto T,. National institutes of Health Chronic Prostatitis Symptom Index for Japanese men. Urology 2002; 60 (1): 74-77. (Pubitemid 34722950)
8. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN,. Chronic prostatitis: Symptom survey with follow-up clinical evaluation. Urology 2003; 61 (1): 60-64. (Pubitemid 36151712)
9. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE,. Pain sensitization in male chronic pelvic pain syndrome: Why are symptoms so difficult to treat ? J Urol 2003; 170 (3): 823-826; discussion 826-827. (Pubitemid 36999566)
10. McNaughton Collins M, Pontari MA, O'Leary MP, Calhoun EA, Santanna J, Landis JR, Kusek JW, Litwin MS,. Quality of life is impaired in men with chronic prostatitis: The Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001; 16 (10): 656-662. (Pubitemid 32964845)
11. Anderson RU, Wise D, Sawyer T, Chan CA,. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: Improvement after trigger point release and paradoxical relaxation training. J Urol 2006; 176 (4 Pt 1): 1534-1538; discussion 1538-1539.
12. Krieger JN, Nyberg L Jr, Nickel JC,. NIH consensus definition and classification of prostatitis. JAMA 1999; 282 (3): 236-237. (Pubitemid 29343164)
13. Haverkamp J, Charbonneau B, Ratliff TL,. Prostate inflammation and its potential impact on prostate cancer: A current review. J Cell Biochem 2008; 103 (5): 1344-1353. (Pubitemid 351490705)
14. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256-269. (Pubitemid 46486616)
15. Elsasser-Beile U, Przytulski B, Gierschner D, Grussenmeyer T, Katzenwadel A, Leiber C, Deckart A, Wetterauer U,. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate. Prostate 2000; 45 (1): 1-7.
16. Pontari MA, Joyce GF, Wise M, McNaughton-Collins M,. Prostatitis. J Urol 2007; 177 (6): 2050-2057. (Pubitemid 46735947)
17. Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, Rivero VE,. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol 2005; 116 (2): 149-157. (Pubitemid 40910241)
18. Klyushnenkova EN, Ponniah S, Rodriguez A, Kodak J, Mann DL, Langerman A, Nishimura MI, Alexander RB,. CD4 and CD8, T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis. J Immunother 2004; 27 (2): 136-146. (Pubitemid 38282733)
19. Vykhovanets EV, Resnick MI, MacLennan GT, Gupta S,. Experimental rodent models of prostatitis: Limitations and potential. Prostate Cancer Prostatic Dis 2007; 10 (1): 15-29. (Pubitemid 46358907)
20. Rivero VE, Cailleau C, Depiante-Depaoli M, Riera CM, Carnaud C,. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun 1998; 11 (6): 603-610. (Pubitemid 29016118)
21. Muntzing J, Sufrin G, Murphy GP,. Prostatitis in the rat. Scand J Urol Nephrol 1979; 13 (1): 17-22. (Pubitemid 9130616)
22. Lundgren R, Holmquist B, Hesselvik M, Muntzing J,. Treatment of prostatitis in the rat. Prostate 1984; 5 (3): 277-284. (Pubitemid 14056559)
23. Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Giarratana N, De Carli E, Fibbi B, Adorini L,. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. J Immunol 2007; 179 (3): 1559-1567.
24. Taguchi O, Nishizuka Y,. Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance. J Exp Med 1987; 165 (1): 146-156. (Pubitemid 17223678)
25. Setiady YY, Ohno K, Samy ET, Bagavant H, Qiao H, Sharp C, She JX, Tung KS,. Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells. Blood 2006; 107 (3): 1056-1062. (Pubitemid 43156305)
26. Kojima A, Prehn RT,. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 1981; 14 (1-2): 15-27. (Pubitemid 12246051)
27. Lees JR, Charbonneau B, Hayball JD, Diener K, Brown M, Matusik R, Cohen MB, Ratliff TL,. T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate 2006; 66 (6): 578-590.
28. Lees JR, Charbonneau B, Swanson AK, Jensen R, Zhang J, Matusik R, Ratliff TL,. Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology 2006; 117 (2): 248-261.
29. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL,. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60 (6): 1541-1545. (Pubitemid 30183422)
30. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL,. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 1998; 95 (9): 5246-5250. (Pubitemid 28208583)
31. Elkahwaji JE, Hauke RJ, Brawner CM,. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer 2009; 101 (10): 1740-1748.
32. Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ,. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology 2005; 66 (4): 883-887. (Pubitemid 41440861)
33. Krieger JN, Riley DE, Cheah PY, Liong ML, Yuen KH,. Epidemiology of prostatitis: New evidence for a world-wide problem. World J Urol 2003; 21 (2): 70-74. (Pubitemid 44175279)
34. Vykhovanets EV, Resnick MI, Marengo SR,. Intraprostatic lymphocyte profiles in aged wistar rats with estradiol induced prostate inflammation. J Urol 2006; 175 (4): 1534-1540.
35. Stoker TE, Robinette CL, Cooper RL,. Perinatal exposure to estrogenic compounds and the subsequent effects on the prostate of the adult rat: Evaluation of inflammation in the ventral and lateral lobes. Reprod Toxicol 1999; 13 (6): 463-472. (Pubitemid 30017323)
36. Mercader M, Bodner BK, Moser MT, Kwon PS, Park ES, Manecke RG, Ellis TM, Wojcik EM, Yang D, Flanigan RC, Waters WB, Kast WM, Kwon ED,. T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc Natl Acad Sci USA 2001; 98 (25): 14565-14570. (Pubitemid 33121432)
37. Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED,. Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 2004; 173 (10): 6098-6108. (Pubitemid 39487766)
38. Liu KJ, Chatta GS, Twardzik DR, Vedvick TS, True LD, Spies AG, Cheever MA,. Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: Implications for prostate cancer therapy. J Immunol 1997; 159 (1): 472-480. (Pubitemid 127493734)
39. Fong L, Ruegg CL, Brockstedt D, Engleman EG, Laus R,. Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: Implications for immunotherapy of prostate cancer. J Immunol 1997; 159 (7): 3113-3117. (Pubitemid 127482067)
40. Hou Y, DeVoss J, Dao V, Kwek S, Simko JP, McNeel DG, Anderson MS, Fong L,. An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans. J Clin Invest 2009; 119 (7): 2031-2041.
41. Robert G, Descazeaud A, Nicolaiew N, Terry S, Sirab N, Vacherot F, Maille P, Allory Y, de la Taille A,. Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis. Prostate 2009; 69 (16): 1774-1780.
42. Bostwick DG, de la Roza G, Dundore P, Corica FA, Iczkowski KA,. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 2003; 55 (3): 187-193. (Pubitemid 36532397)
43. Wang W, Bergh A, Damber JE,. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate 2004; 61 (1): 60-72. (Pubitemid 39095695)
44. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420 (6917): 860-867. (Pubitemid 36019639)
45. McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA,. Leukocytic promotion of prostate cellular proliferation. Prostate 2010; 70 (4): 377-389.
46. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI,. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007; 13 (7): 828-835. (Pubitemid 47038194)
47. Gabrilovich DI, Nagaraj S,. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9 (3): 162-174.